RCS - Oxford Cannabinoid - OCT Company Update with Doceo

Oxford Cannabinoid Technologies HoldingsAnnouncement

03/04/2024 08:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240403:nRSC0207Ja&default-theme=true

RNS Number : 0207J  Oxford Cannabinoid Tech.Holdings  03 April 2024

 

OCT Company Update with Doceo

 

Oxford Cannabinoid Technologies Holdings plc (LSE:OCTP), a clinical stage
biopharmaceutical company focused on the development and commercialisation of
innovative cannabinoid medicines, is pleased to share the following Company
Update video with Doceo.

Clarissa Sowemimo-Coker, Chief Executive Officer, discusses the significant
unmet need for non-addictive treatments to help people living with
debilitating conditions in a global pain market that is estimated to be worth
£75bn by 2027.

 

For further information on Doceo please visit www.doceo.tv
(https://www.doceo.tv/)  or contact the team on info@doceo.tv
(mailto:info@doceo.tv)

 

 

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAZZGGDDZFGDZM